Debt to Equity Ratio Chart

View Debt to Equity Ratio for ORINF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 1999. Start Trial.
Date Value
March 31, 2026 0.2943
December 31, 2025 0.2378
September 30, 2025 0.3056
June 30, 2025 0.3457
March 31, 2025 0.3011
December 31, 2024 0.3256
September 30, 2024 0.2778
June 30, 2024 0.3461
March 31, 2024 0.275
December 31, 2023 0.2248
September 30, 2023 0.2385
June 30, 2023 0.2693
March 31, 2023 0.2893
December 31, 2022 0.2355
September 30, 2022 0.2212
June 30, 2022 0.3382
March 31, 2022 0.2061
December 31, 2021 0.1451
September 30, 2021 0.1453
June 30, 2021 0.1543
March 31, 2021 0.1716
December 31, 2020 0.1485
September 30, 2020 0.1424
June 30, 2020 0.2243
March 31, 2020 0.1886
Date Value
December 31, 2019 0.0128
September 30, 2019 0.0115
June 30, 2019 0.0594
March 31, 2019 0.2609
December 31, 2018 0.196
September 30, 2018 0.2056
June 30, 2018 0.2155
March 31, 2018 0.3666
December 31, 2017 0.2227
September 30, 2017 0.2547
June 30, 2017 0.2751
March 31, 2017 0.308
December 31, 2016 0.2379
September 30, 2016 0.2943
June 30, 2016 0.357
March 31, 2016 0.3913
December 31, 2015 0.3157
September 30, 2015 0.435
June 30, 2015 0.4978
March 31, 2015 0.5742
December 31, 2014 0.4554
September 30, 2014 0.4712
June 30, 2014 0.5447
March 31, 2014 0.648
December 31, 2013 0.5017

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
AstraZeneca PLC 0.7166
ANI Pharmaceuticals, Inc. 1.092
Corcept Therapeutics, Inc. 0.0151
Assertio Holdings, Inc. 0.533
Veru, Inc. 0.0815